Toward the development of a therapeutic program for older prisoners

1977 ◽  
Vol 1 (4) ◽  
pp. 343-348 ◽  
Author(s):  
Ronald Aday
Keyword(s):  
Therapeutic Program ◽  
Older Prisoners

scholarly journals The Health and Well-Being of African-American Older Adults With a History of Incarceration

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 506-506
Author(s):  
Rodlescia Sneed
Keyword(s):  
Older Adults ◽  
African American ◽  
African Americans ◽  
Well Being ◽  
Formerly Incarcerated ◽  
Older Prisoners ◽  
Health Related ◽  
History Of ◽  
Health And Well Being ◽  
African American Older Adults

Abstract African-Americans are overrepresented in the criminal justice system. Longer prison stays and release programs for older prisoners may result in an increased number of community-dwelling older adults with a history of incarceration. In recent years, there has been a substantial increase in research on health-related outcomes for currently incarcerated older adults; however, there has been little inquiry into outcomes for formerly incarcerated African-American older adults following community re-entry. In this study, we used secondary data from the Health and Retirement Study to describe employment, economic, and health-related outcomes in this population. Twelve percent of the 2238 African-Americans in our sample had been previously incarcerated. Those who had been previously incarcerated had higher rates of lung disease, arthritis, back problems, mobility problems, and mental health issues than their counterparts. They also had higher rates of hospitalization and lower use of dental health services. Further, while they did not experience lower employment rates than those with no criminal history, those who had been incarcerated had more physically demanding jobs and reported greater economic strain. Given the disproportionate incarceration rates among African-Americans, the aging of the prison population, and the increase in community re-entry for older prisoners, research that explores factors that impact the health and well-being of formerly incarcerated individuals has broad impact. Future work should focus on addressing the needs of this vulnerable population of African-American older adults.

scholarly journals Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland

2021 ◽  
Vol 10 (4) ◽  
pp. 868
Author(s):  
Katarzyna Kapica-Topczewska ◽  
François Collin ◽  
Joanna Tarasiuk ◽  
Agata Czarnowska ◽  
Monika Chorąży ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Brain Activity ◽  
Brain Mri ◽  
Disability Progression ◽  
Program Monitoring ◽  
Therapeutic Program ◽  
Relapsing Remitting ◽  
Second Year ◽  
Multiple Sclerosis Patients ◽  
Relapsing Remitting Multiple Sclerosis

The aim of the study was to verify the association of clinical relapses and brain activity with disability progression in relapsing/remitting multiple sclerosis patients receiving disease-modifying treatments in Poland. Disability progression was defined as relapse-associated worsening (RAW), progression independent of relapse activity (PIRA), and progression independent of relapses and brain MRI Activity (PIRMA). Data from the Therapeutic Program Monitoring System were analyzed. Three panels of patients were identified: R0, no relapse during treatment, and R1 and R2 with the occurrence of relapse during the first and the second year of treatment, respectively. In the R0 panel, we detected 4.6% PIRA patients at 24 months (p < 0.001, 5.0% at 36 months, 5.6% at 48 months, 6.1% at 60 months). When restricting this panel to patients without brain MRI activity, we detected 3.0% PIRMA patients at 12 months, 4.5% at 24 months, and varying from 5.3% to 6.2% between 36 and 60 months of treatment, respectively. In the R1 panel, RAW was detected in 15.6% patients at 12 months and, in the absence of further relapses, 9.7% at 24 months and 6.8% at 36 months of treatment. The R2 group was associated with RAW significantly more frequently at 24 months compared to the R1 at 12 months (20.7%; p < 0.05), but without a statistical difference later on. In our work, we confirmed that disability progression was independent of relapses and brain MRI activity.

scholarly journals ‘A sense of purpose’: Older prisoners’ experiences of successful ageing behind bars

2021 ◽  
pp. 147737082199514
Author(s):  
Hila Avieli
Keyword(s):  
Old Age ◽  
Environmental Conditions ◽  
Older Men ◽  
Phenomenological Analysis ◽  
Interpretive Phenomenological Analysis ◽  
Successful Ageing ◽  
Older Prisoners ◽  
Unified Process ◽  
Self Discovery ◽  
Better Than

There is growing interest in ageing offenders and their lives in prison. However, this subject is often studied from a deprivation perspective, focusing on issues such as lack of medical care and proper environmental conditions. This article highlights experiences of wellbeing while ageing in confinement, using the conceptual framework of successful ageing. An interpretive phenomenological analysis perspective was used to analyse the narratives of 18 older prisoners. The narratives revealed four themes: ‘Like all other older men’: comparing ageing in prison with ageing within the community; ‘Better than what I have outside’: prison as an escape from a life of loneliness, poverty and delinquency; ‘Here I get some respect’: the older prisoner as a mentor; and ‘I feel accomplished’: experiences of growth and self-discovery as a means for successful ageing in prison. The findings suggest that ageing in prison may not be perceived as a single, unified process, but as a personal and individual phenomenon, and that old age may facilitate positive changes in the lives of ageing offenders in prison.

Wilderness Camping as a Therapy for Emotionally Disturbed Children: A Critical Review

1979 ◽  
Vol 45 (8) ◽  
pp. 628-635 ◽  
Author(s):  
E. Sandra Byers
Keyword(s):  
Critical Review ◽  
Emotionally Disturbed ◽  
Evaluation Research ◽  
Disturbed Child ◽  
Short Term ◽  
Minimal Support ◽  
Therapeutic Program ◽  
Good Setting ◽  
Therapeutic Camping

The wilderness camp has been described as a particularly good setting for treatment of the emotionally disturbed child. This article summarizes the current literature on therapeutic camping, including the nature of existing programs, rationales for the superiority of camping as a therapeutic program, and evaluation of existing programs. The results of program evaluation research reported in the literature provide only minimal support for any particular effectiveness ascribed to therapeutic camping in terms of either short term or long term therapeutic outcome. This is seen to be largely due to inadequate investigation of the process and/or the outcome of therapeutic camping.

scholarly journals MBCL-04. 5 – AZACYTIDINE IN TREATMENT OF CHILDREN WITH DE NOVO AND RELAPSED METASTATIC MEDULLOBLASTOMA: RESULTS OF INTERCENTER PILOT STUDY

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii387-iii387
Author(s):  
Andrey Levashov ◽  
Dmitry Khochenkov ◽  
Anna Stroganova ◽  
Marina Ryzhova ◽  
Sergey Gorelyshev ◽  
...  
Keyword(s):  
Gene Amplification ◽  
De Novo ◽  
Prognostic Significance ◽  
N Gene ◽  
Free Survival ◽  
Tumor Bed ◽  
Craniospinal Radiation ◽  
Therapeutic Program ◽  
Grade 3

Abstract The aim of this study was to estimate treatment toxicity and event-free survival (EFS) according to therapeutic program, MYC/MYC-N gene amplification and MGMT/DNMT (1, 3a, 3b) proteins expression in tumor cells. From 2016 to 2018 twenty four patients were included in trial. Children underwent adjuvant therapy: craniospinal radiation (CSI) or local radiation therapy (RT) to the relapsed site up to 23.4Gy with 5-azacytidine, 2 cycles methotrexate/5-azacytidine/cisplatin/etoposide, 3 cycles 5-azacytidine/temozolomide - for relapsed group (arm A, n = 5); for patients with de novo medulloblastoma: arm B, n = 11 – vincristine/cyclophosphamide/cisplatin/etoposide (OPEC) - based induction, CSI 36Gy + local RT to the tumor bed up to 54Gy with 5-azacytidine, 1 cycle OPEC and 2 cycles thiophosphamide/carboplatin with auto stem cell transplantation (auto-SCT); arm C, n = 8 – cyclophosphamide/cisplatin - based induction, CSI 23.4 Gy followed by 2 cycles 5-azacytidine/thiophosphamide/carboplatin with auto-SCT, local RT with 5-azacytidine. The combination of 5-azacytidine with local RT or temozolomide was safety and tolerability. Arm C was discontinued due to severe gastrointestinal grade 3/4 toxicity, hemorrhagic syndrome after combination of 5-azacytidine with thiophosphamide/carboplatin. EFS was 0% in arm A, 53.0 ± 15.5%, 50.0 ± 17.7% in arms B and C, a median follow-up 8.8 ± 1.1 months (arm A), 18.8 ± 2.5 months (arm B), 25.0 ± 4.4 months (arm C). Addition of 5-azacytidine to RT or chemotherapy did not improve EFS of patients with MYC/MYC-N gene amplification positive tumor. There was not determined any prognostic significance of MGMT/DNMT (1, 3a, 3b) proteins expression in this cohort.

Letters to the Editor

PEDIATRICS ◽  
1971 ◽  
Vol 47 (2) ◽  
pp. 472-472
Author(s):  
Harry Shwachman
Keyword(s):  
Cystic Fibrosis ◽  
Letters To The Editor ◽  
Therapeutic Program

In reply to the letter of Dr. Phillip A. Cohen I should like to point out that the article referred to was designed primarily to present the advantages accrued from establishing a diagnosis of cystic fibrosis early in life and instituting a therapeutic program. To outline this therapeutic program in detail was not the purpose of the paper. The opening statement in the paragraph discussing treatment refers to Shirkey's Pediatric Therapy and I should like to quote from this chapter, second edition (1966-1967), page 536:

Sign in / Sign up

Export Citation Format

Share Document